 |
0 Diseases |  |
3 Trials |
|
3 Trials |  |
45 News |  |
| «12 |
- ||| Tagrisso (osimertinib) / AstraZeneca, Zorifer (zorifertinib) / Alpha Biopharma, AstraZeneca
Metastases: BLOOM: Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer (clinicaltrials.gov) - Aug 29, 2014
P1, N=83, Not yet recruiting, Sponsor: AstraZeneca